Zimmer Biomet Says Fatal Flaws Doom $3B Del. Cashout Suit
Attorneys for Zimmer Biomet Holdings Inc. directors and investors attacked as "not plausible" Tuesday a Delaware Chancery Court stockholder suit seeking damages for allegedly undisclosed company woes that led to a...To view the full article, register now.
Already a subscriber? Click here to view full article